Envoy Medical (COCHW) Cash & Current Investments (2021 - 2026)

Envoy Medical has disclosed Cash & Current Investments across 6 years of filings, most recently posting $25.3 million for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $25.3 million, up 375.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.3 million (up 375.36% YoY), and the FY2025 annual result was $3.7 million, down 31.81% from the prior year.
• Cash & Current Investments came in at $25.3 million for Q1 2026 at Envoy Medical, up from $3.7 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $25.3 million in Q1 2026 to a low of $68000.0 in Q2 2023.
• The 5-year median for Cash & Current Investments is $4.0 million (2023), against an average of $5.5 million.
• Across the five-year window, Cash & Current Investments slumped 94.1% in 2022 and jumped 7264.31% in 2023, its largest moves.
• Envoy Medical's Cash & Current Investments stood at $183000.0 in 2022, then surged by 2205.46% to $4.2 million in 2023, then grew by 29.96% to $5.5 million in 2024, then sank by 31.81% to $3.7 million in 2025, then soared by 575.34% to $25.3 million in 2026.
• The last three Cash & Current Investments figures came in at $25.3 million (Q1 2026), $3.7 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.